Clym has announced the release of HIPAA Authorization for Healthcare Web Tracking Consent, a new capability designed to help healthcare organizations manage consent for online tracking activities involving health-related data. The launch addresses a growing challenge as healthcare websites increasingly rely on analytics and third-party services that may involve protected health information.
Standard cookie consent tools were developed primarily for general consumer privacy laws and are not designed to capture HIPAA-specific authorization requirements. As a result, healthcare organizations often face gaps between how website consent is collected and how HIPAA authorization is expected to be handled when health-related data is disclosed to third parties.
“HIPAA authorization requires a different approach than traditional cookie consent,” said a Clym spokesperson. “This release is focused on giving healthcare organizations a clearer way to manage authorization for web tracking activities within their broader consent workflows.”
The new capability extends Clym’s broader consent management system, allowing organizations to handle HIPAA authorization alongside cookie consent, marketing preferences, and advertising consent frameworks. Through the same interface, teams can manage controls for tracking technologies and advertising signals such as Google Consent Mode V2, with configurations applied automatically and without the need for manual or technical setup.
This approach reflects Clym’s all-in-one digital compliance solution, bringing consent management, accessibility tools, and transparency features into one platform. Consolidating these functions helps organizations reduce the need for multiple vendors while maintaining clearer oversight of digital compliance activities.
The announcement comes as regulators and privacy experts continue to scrutinize how health-related data is collected and shared online. According to the U.S. Department of Health and Human Services, hundreds of large healthcare data breaches affecting tens of millions of individuals were recorded in 2025, highlighting the sensitivity of healthcare data in digital environments.
This approach reflects Clym’s all-in-one digital compliance solution, which integrates consent management, accessibility tools, and transparency features into a single, streamlined platform. By centralizing these critical functions, the solution simplifies what is often a fragmented and complex compliance landscape. Organizations no longer need to rely on multiple third-party vendors to manage separate regulatory requirements, which can lead to operational inefficiencies, inconsistent reporting, and increased compliance risk.
Bringing these capabilities together enhances coordination across privacy, accessibility, and governance teams, enabling a more unified compliance strategy. It also provides leadership with clearer visibility into digital compliance activities through consolidated dashboards and reporting tools. This improved oversight supports better decision-making, faster response to regulatory changes, and more effective risk mitigation.
Ultimately, consolidating compliance tools into one cohesive system reduces administrative burden, lowers operational costs, and strengthens accountability. Organizations benefit from a simplified vendor ecosystem while maintaining stronger control over evolving regulatory obligations in today’s dynamic digital environment.
Bringing these capabilities together enhances coordination across privacy, accessibility, and governance teams, enabling a more unified compliance strategy. It also provides leadership with clearer visibility into digital compliance activities through consolidated dashboards and reporting tools. This improved oversight supports better decision-making, faster response to regulatory changes, and more effective risk mitigation.
through consolidated dashboards and reporting tools. This improved oversight supports better decision-making, faster response to regulatory changes, and more effective risk mitigation.
